Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIQE Regulatory News (IQE)

Share Price Information for IQE (IQE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 28.10
Bid: 0.00
Ask: 39.75
Change: 0.00 (0.00%)
Spread: 12.00 (43.243%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 28.10
IQE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Contract Win

28 Sep 2007 10:14

IQE PLC28 September 2007 28 September 2007 IQE plc IQE to team with Raytheon as part of $6.5m US government contract win. IQE plc (AIM: IQE), the UK-based leading outsource supplier of advanced wafersand outsource wafer services to the global semiconductor industry , announcesthat its Pennsylvania based manufacturing facility is to be part of a team ledby US defense contractor Raytheon, to integrate high-performance compoundsemiconductors with low-cost commercial complementary metal oxide semiconductorsilicon (CMOS) wafers. This will achieve superior cost-benefit performancecompared with either technology on its own. Raytheon (NYSE: RTN) announced yesterday that it had been awarded a $6.5 millioncontract to develop affordable, high-performance semiconductor integratedcircuits for electronic-driven military systems. The US Defense AdvancedResearch Projects Agency (DARPA) is funding the contract as part of its CompoundSemiconductor Materials on Silicon (COSMOS) program. Dr. Katherine Herrick, Raytheon Integrated Defense Systems (IDS) program managercommented: "The objective is to develop a high-resolution analog-to-digital converter withlow power consumption. However, the benefits of the program go significantlybeyond the specific objective. The processes lead to advanced low-cost analogand digital, microwave and millimeter-wave integrated circuits with applicationsfor next-generation radar, communications and electronic warfare systems." Mark Russell, vice president, IDS Engineering. "Our team's process of directly growing a compound semiconductor on a uniquelyengineered silicon substrate provides a new technical approach that is creatinga class of integrated circuits that will enable more affordable systems for thewarfighter. Steve Gergar, IQE's Vice President and General Manager in Bethlehem PA said: "IQE has enjoyed a long relationship with Raytheon and is pleased to be part ofthe team to share in this latest US government funded program. IQE's role inthis important project demonstrates our reputation for expertise, experience andquality in advanced semiconductor materials manufacturing processes for bothcurrent and future applications" Other partners in the COSMOS project are Raytheon Systems Limited in Glenrothes,Scotland; Teledyne Scientific Imaging Company in Thousand Oaks, Calif.;Massachusetts Institute of Technology in Cambridge, Mass.; Paradigm Research LLCin Windham, N.H.; Soitec in Grenoble, France; and Silicon Valley TechnologyCenter in San Jose, Calif. Integrated Defense Systems is Raytheon's leader in Joint Battlespace Integrationproviding affordable, integrated solutions to a broad international and domesticcustomer base, including the U.S. Missile Defense Agency, the U.S. Armed Forcesand the Department of Homeland Security. Contacts: IQE plc : www.iqep.com Drew Nelson +44 (0)29 2083 9400Phil RasmussenChris Meadows College Hill:Adrian Duffield / Ben Way +44 (0)20 7457 2020 Noble and Company :John Llewellyn-Lloyd/ Sam Reynolds + 44 (0) 20 7763 2200 NOTE TO EDITORS IQE IQE is the leading global supplier of advanced semiconductor wafers withproducts that cover a diverse range of applications, supported by an innovativeoutsourced foundry services portfolio that allows the Group to provide a 'onestop shop' for the wafer needs of the world's leading semiconductormanufacturers. IQE uses advanced crystal growth technology (epitaxy) to manufacture and supplybespoke semiconductor wafers ('epi-wafers') to the major chip manufacturingcompanies, who then use these wafers to make the chips which form the keycomponents of virtually all high technology systems. IQE is unique in being ableto supply wafers using all of the leading crystal growth technology platforms. IQE's products are found in many leading-edge consumer, communication, computingand industrial applications, including a complete range of wafer products forthe wireless industry, such as mobile handsets and wireless infrastructure,Wi-Fi, WiMAX, base stations, GPS, and satellite communications; opticalcommunications, optical storage (CD, DVD), laser optical mouse, laser printers &photocopiers, thermal imagers, leading-edge medical products, barcode, highefficiency LEDs and a variety of advanced silicon based systems. The manufacturers of these chips are increasingly seeking to outsource waferproduction to specialist foundries such as IQE in order to reduce overall wafercosts and accelerate time to market. IQE also provides bespoke R&D services to deliver customised materials forspecific applications and offers specialist technical staff to manufacture tospecification either at its own facilities or on the customer's own sites. TheGroup is also able to leverage its global purchasing volumes to reduce the costof raw materials. In this way IQE's outsourced services, provide compellingbenefits in terms of flexibility and predictability of cost, therebysignificantly reducing operating risk. IQE operates six manufacturing facilities located in Cardiff (two) and MiltonKeynes in the UK; in Bethlehem, Pennsylvania and Somerset, New Jersey in theUSA; and Singapore. The Group also has 11 sales offices located in majoreconomic centres worldwide. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
8th Mar 20133:00 pmRNSMerger Update
8th Jan 20138:39 amRNSStatement regarding press articles
31st Jul 20123:54 pmRNSDirectorate Change
10th Apr 20125:11 pmRNSDirector Dealings
27th Mar 20122:00 pmRNSPartnership Agreement
8th Feb 20124:10 pmRNSCompletion of Placing
17th Feb 20103:56 pmRNSNominated Adviser Change of Name
7th Aug 20094:42 pmRNSHolding(s) in Company
7th Aug 20094:30 pmRNSBondholders meeting
7th Aug 20093:51 pmRNSDirector Dealing in Shares
12th Jun 20081:42 pmRNSAdditional Listing
15th Apr 20087:01 amRNSAdditional Listing
7th Apr 200812:14 pmRNSDirector/PDMR Shareholding
28th Mar 200811:52 amRNSDirector/PDMR Shareholding
19th Mar 20087:00 amRNSDirector/PDMR Shareholding
17th Mar 20081:00 pmRNSContract Win
17th Mar 20087:01 amRNSFinal Results
28th Feb 20083:27 pmRNSHolding(s) in Company
19th Feb 20088:30 amRNSNotice of Results
25th Jan 20087:00 amRNSBank Facilities
17th Jan 20087:00 amRNSTrading Update
16th Jan 200811:15 amRNSBroker Appointment
15th Jan 200812:12 pmRNSDirector/PDMR Shareholding
9th Jan 20084:26 pmRNSAdditional Listing
7th Jan 20087:00 amRNSDirector/PDMR Shareholding
4th Jan 200812:46 pmRNSHolding(s) in Company
19th Dec 20077:30 amRNSAdditional Listing
18th Dec 20073:52 pmRNSSubstrate supply contract
13th Dec 20077:01 amRNSSuccessful Qualifications
9th Nov 200710:53 amRNSDirector/PDMR Shareholding
3rd Oct 200710:41 amRNSDirector/PDMR Shareholding
1st Oct 20072:44 pmRNSAdditional Listing
28th Sep 200710:14 amRNSContract Win
28th Sep 20078:12 amRNSInvestor Presentation
4th Sep 200712:03 pmRNSDirector/PDMR Shareholding
28th Aug 20072:17 pmRNSHolding(s) in Company
24th Aug 20073:36 pmRNSHolding(s) in Company
22nd Aug 20077:01 amRNSContract Win
22nd Aug 20077:01 amRNSInterim Results
15th Aug 20077:01 amRNSIFRS Transitional Stmnt - Amd
14th Aug 20077:01 amRNSIFRS Transitional Statement
13th Aug 20071:19 pmRNSRule 26 Compliance
2nd Aug 20078:39 amRNSResearch Consortium
1st Aug 20073:52 pmRNSNotice of Results
25th Jul 20071:35 pmRNSResult of AGM
11th Jul 20078:00 amRNSHolding(s) in Company
9th Jul 20077:00 amRNSTrading Statement
18th Jun 20073:35 pmRNSHolding(s) in Company
4th Jun 20074:15 pmRNSHolding(s) in Company
29th May 20074:48 pmRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.